Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancers and enhancing efficacy of BCMAxCD3 bispecific antibodies

Methods of treating cancers and enhancing efficacy of BCMAxCD3 bispecific antibodies

US Patent 12098210 · Granted Sep 24, 2024

Estimated economic value: $579,759,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses2024
Methods for treating multiple myeloma2024
Methods for treating multiple myeloma2024
Anti-CEACAM antibodies and uses thereof2023
Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses2021
FGFR/PD-1 combination therapy for the treatment of cancer2019